Keyphrases
Endotoxin
100%
Phosphodiesterase Inhibition
100%
Endotoxemia
100%
Cardiac Effects
100%
Cytokine Release
100%
Heart Rate
57%
Interleukin-1β
42%
Ventricular End-diastolic Pressure
42%
Tumor Necrosis Factor-α
42%
Plasma Renin Activity
42%
Plasma Parameters
28%
High Dose
28%
PDE4 Inhibition
28%
Anesthetized Rats
28%
Renal Function
28%
Left Ventricular End-diastolic Pressure
28%
Catecholamine Levels
28%
Phosphodiesterase-4 (PDE4)
28%
Inflammatory Cytokines
14%
Noradrenaline
14%
Protective Effect
14%
Systolic Pressure
14%
Fold Increase
14%
PDE4 Inhibitor
14%
Adrenaline
14%
Beneficial Effects
14%
Pressure Rate
14%
Phosphodiesterase
14%
Acute Renal Failure
14%
Diastolic Function
14%
Rate Pressure Product
14%
Urinary Catecholamines
14%
Diastolic Pressure
14%
Cardiac Performance
14%
Inflammatory Cytokine Response
14%
Performance Parameters
14%
Heart Performance
14%
Survivability
14%
Activity Level
14%
Lipopolysaccharide-induced
14%
Medicine and Dentistry
Endotoxin
100%
Endotoxemia
100%
Cytokine Release
100%
Phosphodiesterase IV
100%
Renin
42%
Heart Ventricle Enddiastolic Pressure
42%
Interleukin 1
42%
Tumor Necrosis
42%
Drug Megadose
28%
Fibrinogen
28%
Heart Left Ventricle Pressure
28%
Catecholamine
28%
Kidney Function
28%
Heart Performance
28%
Inflammatory Cytokine
28%
Noradrenalin
14%
Systolic Blood Pressure
14%
Diastolic Blood Pressure
14%
Acute Kidney Injury
14%
Phosphodiesterase IV Inhibitor
14%
Epinephrine
14%
Lipopolysaccharide
14%
Diastolic Function
14%
Dimethyl Sulfoxide
14%
Pharmacology, Toxicology and Pharmaceutical Science
Cytokine
100%
Phosphodiesterase IV
100%
Endotoxin
100%
Endotoxemia
100%
Tumor Necrosis
42%
Renin
42%
Interleukin 1
42%
Catecholamine
28%
Fibrinogen
28%
Noradrenalin
14%
Dimethyl Sulfoxide
14%
Phosphodiesterase IV Inhibitor
14%
Lipopolysaccharide
14%
Acute Kidney Failure
14%
Epinephrine
14%